🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Only subjects that have completed TILS-021, a Phase 2a Randomized, Double-B...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2025-03-04
Trial ID
NCT06890923
Treatments Being Tested
This is an open-label, intermediate-size patient population expanded access...
Status
Available
Location
Brigham and Women's Hospital
Start Date
TBD
Trial ID
NCT06802328
Treatments Being Tested
The specific aims of the study are: Primary: To determine the presence and...
Status
Recruiting
Location
Brigham MS Center, 60 Fenwood Road
Start Date
2016-05-02
Trial ID
NCT02649985
Treatments Being Tested
The goal of this clinical trial is to learn whether a nasal spray medicine ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-25
Trial ID
NCT07688239
Treatments Being Tested
This is a Phase 2, randomized, placebo-controlled, double-blind, proof-of-c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-30
Trial ID
NCT04983446
This is a randomized, placebo-controlled, four-arm, double-blind study. Sub...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12-01
Trial ID
NCT03291249
Treatments Being Tested
The primary objective is to establish the safety of administration of intra...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05029609
Treatments Being Tested
A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atroph...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2025-05-19
Trial ID
NCT06868628
Treatments Being Tested
The primary objective of this study is to establish the safety and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05-01
Trial ID
NCT05028946
Treatments Being Tested
The goal is to establish the safety of administration of nasal foralumab to...
Status
Completed
Location
Ann Romney Center for Neurologic Diseases
Start Date
2018-11-12
Trial ID
NCT06879067
Treatments Being Tested